Nuvation Bio NUVB Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -338.7%+7,189pp | -7,527.3%— | —— | —— | |
| Net margin | -325.3%+6,888pp | -7,213.8%— | —— | —— | |
| Returns | |||||
| Return on equity | -53.2%+53.1pp | -106.3%-94.2pp | -12%+2.8pp | -14.9%+3.2pp | |
| Return on invested capital | -67%+51.1pp | -118.1%-100pp | -17.8%+2.6pp | -20.4%+2.8pp | |
| Efficiency | |||||
| Asset turnover | 0.1×+0.1× | 0×— | 0×— | —— | |
| Liquidity | |||||
| Current ratio | 7×-2.1× | 9×-35.1× | 44.1×-6.6× | 50.7×+5.1× | |
| Leverage | |||||
| Debt-to-equity | 0.2×+0.2× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | |||||
| Book value per share | $0.90-48.1% | $1.73-37.6% | $2.76-8.5% | $3.02-19.8% | |
| Valuation | |||||
| Market capitalization | $3.07B+243% | $895.27M+171% | $330.68M-21.2% | $419.51M-76.9% | |
| Price / sales | 48.8×-64.9× | 113.7×— | —— | —— | |
| Price / book | 10×+8.1× | 1.9×+1.4× | 0.5×-0.1× | 0.6×-1.8× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nuvation Bio's profit margins?
- Nuvation Bio (NUVB) runs a 54.3% gross margin and a -105.0% operating margin, with a -102.1% net margin.
- Where do Nuvation Bio's ratios come from?
- Every ratio is computed from Nuvation Bio's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
